Minerva Neurosciences, Inc.
NERV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,439 | -$30,005 | -$32,109 | -$49,906 |
| Dep. & Amort. | $22 | $31 | $9 | $102 |
| Deferred Tax | $0 | $0 | $0 | -$1,803 |
| Stock-Based Comp. | $1,326 | $1,968 | $4,109 | $5,219 |
| Change in WC | -$321 | $4,938 | -$4,060 | $259 |
| Other Non-Cash | -$22,017 | $8,283 | $7,407 | $21,527 |
| Operating Cash Flow | -$19,551 | -$14,785 | -$24,645 | -$24,602 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$16 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$16 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $20,000 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$396 | -$0 | $60,000 |
| Financing Cash Flow | $0 | $19,604 | -$0 | $60,000 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$19,551 | $4,819 | -$24,661 | $35,398 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,013 | $36,194 | $60,855 | $25,457 |
| End Cash | $21,462 | $41,013 | $36,194 | $60,855 |
| Free Cash Flow | -$19,551 | -$14,785 | -$24,661 | -$24,602 |